Co-Diagnostics, Inc. Interest Expense on Debt
Co-Diagnostics, Inc. (CODX) reported Interest Expense on Debt of $106.41 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2020-03-30
- Co-Diagnostics, Inc. interest expense, debt for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
- Co-Diagnostics, Inc. interest expense, debt for the quarter ending 2019-09-30 was $0.00, a 100.00% decline year-over-year.
- Co-Diagnostics, Inc. interest expense, debt for the quarter ending 2019-06-30 was $0.00.
- Co-Diagnostics, Inc. interest expense, debt for the quarter ending 2019-03-31 was $106.41K.
- Co-Diagnostics, Inc. interest expense, debt for fiscal 2019 was $106.41K, a 49.87% increase from fiscal 2018.
- Co-Diagnostics, Inc. interest expense, debt for fiscal 2018 was $71.00K, a 77.11% decline from fiscal 2017.
- Co-Diagnostics, Inc. interest expense, debt for fiscal 2017 was $310.23K.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $106.41K 10-K · filed 2020-03-30 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 derived: sum of 2 quarters · filed 2019-11-12 | $106.41K 10-Q · filed 2019-11-12 | $151.41K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $106.41K 10-Q · filed 2019-08-14 | $151.41K derived: sum of 3 quarters · filed 2020-03-30 | $177.41K derived: sum of 4 quarters · filed 2020-03-30 |
| 2019-03-31 | $106.41K 10-Q · filed 2019-05-14 | $151.41K derived: sum of 2 quarters · filed 2020-03-30 | $177.41K derived: sum of 3 quarters · filed 2020-03-30 | |
| 2018-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $71.00K derived: sum of 2 quarters · filed 2020-03-30 | $71.00K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $26.00K 10-Q · filed 2018-11-14 | $26.00K 10-Q · filed 2018-11-14 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $14.80K derived: sum of 2 quarters · filed 2019-04-01 | $310.23K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $14.80K 10-Q · filed 2018-11-14 | $310.23K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |